Skip to main content

Table 2 Perioperative patients details

From: St. Jude Medical Trifecta aortic valve: results from a prospective regional multicentre registry

Variablesa

All implants (n = 178)

Valve size implanted, n (%)

 

 19 mm

31 (17.4)

 21 mm

58 (32.6)

 23 mm

58 (32.6)

 25 mm

24 (13.5)

 27 mm

7 (3.9)

Operative data

 

 Isolated AVR, n (%)

81 (45.5)

 CABG, n (%)

63 (35.4)

 ACC time, min

67.9 ± 41.4 (45-95)

 CPB time, min

103.9 ± 45.7 (70-131)

Postoperative data

 

 IABP, n (%)

6 (3.4)

 Re-exploration for bleeding, n (%)

7 (3.9)

 Stroke, n (%)

2 (1.1)

 Respiratory failure, n (%)

14 (7.9)

 Acute kidney injury, n (%)

24 (13.5)

 Renal replacement therapy, n (%)

11 (6.2)

 Atrial fibrillation, n (%)

79 (44.4)

 Ventilation, hours

33.8 ± 98.8 (7-24)

 ICU stay, hours

68.5 ± 119.2 (24-60)

 Hospital mortality, n (%)

5 (2.8)

  1. aFor continuous variables, mean ± SD (interquartile range); categorical data, count (percentage)
  2. ACC aortic cross clamp time, AVR aortic valve replacement, CABG coronary artery bypass grafting, CPB cardiopulmonary bypass, IABP intra-aortic balloon pump, ICU intensive care unit